Louis Chrystal bought TCRX
January 3, 2025 · Form 4 insider transaction
Louis Chrystal bought 400,000 shares of TScan Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 39 days after the transaction.
Direction
Acquired (buy-side)
Shares
400,000
Price
$0.00
Total value
N/A
InsiderLouis Chrystal
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 3, 2025
Filing dateFebruary 11, 2025
Shares owned after400,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 3, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.